LANA HULBERT: Open Payments
NPI 1750772646 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,019 in 127 payments from 19 companies in 2025. Trend: 2023 $3,072 · 2024 $2,067 · 2025 $2,019
Food & beverage: $2,019
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $557 |
| Novo Nordisk Inc | 23 | $325 |
| PFIZER INC. | 14 | $237 |
| GlaxoSmithKline, LLC. | 13 | $153 |
| Lilly USA, LLC | 7 | $118 |
| Exact Sciences Corporation | 5 | $95 |
| Amgen Inc. | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 2 | $53 |
| Antares Pharma, Inc. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
Products named: QULIPTA, VRAYLAR, TRELEGY ELLIPTA, Wegovy, ELIQUIS, Cologuard Collection Kit, MOUNJARO, JARDIANCE.
Industry payments across PA — which companies pay providers there.
